News
Better Dividend Stock: AT&T vs. Verizon
Income-seeking investors want to turn their heads toward the telecommunications industry. Two members of America's three-way telecom oligopoly offer huge dividend yields above 6% at the moment.
Veri
Is Viking Therapeutics Incredibly Undervalued?
Viking Therapeutics (NASDAQ: VKTX) has emerged as a beacon of hope in an otherwise lackluster year for healthcare stocks. The buzz around its mid-stage weight loss candidate, VK2735, has propelled
Can This High-Flying Stock 10x in 10 Years?
Viking Therapeutics (NASDAQ: VKTX) has been flying on all cylinders since the beginning of the year. The company's shares are up 246% due to excellent clinical progress. It's not rare for smaller
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
Last Friday, Agenus (NASDAQ: AGEN), an immuno-oncology player, saw its shares soar by a staggering 40.8%. This remarkable rally occurred seemingly without a clear catalyst. The company is set to
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Income investors can be growth investors, too. Granted, it's not always easy to find stocks that pay generous dividends and offer solid prospects of share price appreciation. However, such stocks
Better Dividend Stock: AbbVie or Johnson & Johnson?
There are many dividend stocks on the market, but few are as prominent as AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ). These companies have raised their payouts for over 50 consecutive
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Buying stocks based on one aspect of a company is a mistake, but often, investors get fixated. Income-focused investors, for example, often give dividend yield too much sway in their investment
3 Dividend Stocks to Buy and Hold for the Next Decade
Buy, hold, rake in solid income. That sounds like a pretty good investing strategy. You only have to find the right stocks worthy of holding for the long term and that pay attractive dividends.
It's Time to Buy AT&T Stock Hand Over Fist
Telecom giant AT&T (NYSE: T) slightly missed expectations for revenue and earnings when it reported its first-quarter results on Wednesday, but those headline figures don't tell the whole story
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
By almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant delivered first-quarter sales and earnings results that topped estimates. The decline in sales of
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
"If you don't find a way to make money while you sleep, you will work until you die." That's a quote from billionaire investor Warren Buffett which emphasizes the importance of making your money
Valbiotis publishes its annual accounts 2023
Merck (MRK) Q1 2024 Earnings Call Transcript
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
AstraZeneca Plc (NASDAQ: AZN)Q1 2024 Earnings CallApr 25, 2024, 6:45 a.m. ET
Operator
Source Fool.com
2 Fantastic Growth Stocks to Buy Right Now
While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last
Is AT&T a Buy Now?
Shares of AT&T (NYSE: T) recently slipped about half a percentage point in response to first-quarter results that the telecom giant announced before the market opened on April 24.
First-quarter
Why Biogen Stock Leaped Nearly 5% Higher Today
Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded
Why AT&T Stock Ticked Up Today
Shares of AT&T (NYSE: T) were moving higher today. Investors applauded its latest quarterly results as the telecom giant easily beat expectations on the top and bottom lines.
As a result, the
Biogen (BIIB) Q1 2024 Earnings Call Transcript
AT&T; (T) Q1 2024 Earnings Call Transcript
EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
3 Dividend-Paying Tech Stocks to Buy in April
One of the best things about investing in stocks is that you don't always need share-price growth to make money. Thanks to dividends, investors can be rewarded regardless of a company's stock price
EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
Why Novartis Stock Topped the Market on Tuesday
Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release